FH and paroxysmal nocturnal hemoglobinuria: Engineered variants of FH could be relevant in the treatment of PNH as in vitro studies already showed that both miniFH and midiFH are effective in protecting PNH erythrocytes from complement-mediated lysis (195, 197).